Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera

Guilin Tang, Juliana E. Hidalgo Lopez, Sa A. Wang, Shimin Hu, Junsheng Ma, Sherry Pierce, Wenli Zuo, Adrian Alejandro Carballo-Zarate, C. Cameron Yin, Zhenya Tang, Shaoying Li, L. Jeffrey Medeiros, Srdan Verstovsek, Carlos E. Bueso-Ramos

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

Up to 20% of patients with polycythemia vera have karyotypic abnormalities at the time of the initial diagnosis. However, the cytogenetic abnormalities in polycythemia vera have not been well characterized and their prognostic impact is largely unknown. In this study, we aimed to address these issues using a large cohort of polycythemia vera patients with cytogenetic information available. The study included 422 patients, 271 in polycythemic phase, 112 with postpolycythemic myelofibrosis, 11 in accelerated phase, and 28 in blast phase. Abnormal karyotypes were detected in 139 (33%) patients, ranging from 20% in those in the polycythemic phase to 90% among patients in accelerated/blast phase. Different phases harbored different abnormalities: isolated del(20q), +8 and +9 were the most common abnormalities in the polycythemic phase; del(20q) and +1q were the most common abnormalities in post-polycythemic myelofibrosis; and complex karyotypes were the most common karyotypes in accelerated and blast phases. Patients with an abnormal karyotype showed a higher frequency of disease progression, a shorter transformation-free survival and an inferior overall survival compared with patients with a normal karyotype in the same disease phase. Cytogenetics could be effectively stratified into three risk groups, low-(normal karyotype, sole +8, +9 and other single abnormality), intermediate-(sole del20q, +1q and other two abnormalities), and high-risk (complex karyotype) groups. We conclude that cytogenetic changes in polycythemia vera vary in different phases of disease, and carry different prognostic impacts.

Original languageEnglish (US)
Pages (from-to)1511-1518
Number of pages8
JournalHaematologica
Volume102
Issue number9
DOIs
StatePublished - Aug 31 2017

ASJC Scopus subject areas

  • Hematology

MD Anderson CCSG core facilities

  • Biostatistics Resource Group

Fingerprint

Dive into the research topics of 'Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera'. Together they form a unique fingerprint.

Cite this